Search

everythinglearnresearchcommunity

for

Search:↓

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Scientists developed tools to observe hair regeneration in real time and assess skin health, using glowing mice and light-controlled genes.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Bacterial cellulose is a promising material for biomedical uses but needs improvements in antimicrobial properties and degradation rate.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The study found that the protein Dkk4 helps regulate hair growth by controlling Wnt signaling in mice.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Minoxidil increases cell layer permeability by reducing tight junction proteins and raising ROS levels.

A group has developed therapies that show promise for treating cancer and various other conditions.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Key genes linked to hair growth and cancer were identified in hairless mice.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.